Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and the safety of ASC-01 (aripiprazole/sertraline combination)
compared to sertraline monotherapy in patients with major depressive disorders who have
responded incompletely to sertraline monotherapy.